CYP2C19⁎2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls.

doi:10.1155/2017/5783719

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

CYP2C19⁎2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls.

BioMed research international - 1 Jan 2017

Ruedlinger Jenny, Prado Yalena, Zambrano Tomás, Saavedra Nicolás, Bobadilla Braulio, Potthoff Marcelo, Pérez Luis, Lanas Fernando, Salazar Luis A

Abstract excerpt

Clopidogrel is an antiplatelet drug especially used in patients undergoing percutaneous coronary interventions (PCI). Polymorphisms within CYP2C19 can result in important interindividual variations regarding therapeutic efficacy. Therefore, we aimed to evaluate the impact of the CYP2C19⁎2 variant (rs4244285) on in-stent restenosis occurrence in Chilean patients who underwent PCI and received clopidogrel. A total...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chile

Share to Coronary Angiography

Share to Coronary Restenosis

Share to Cytochrome P-450 CYP2C19

Share to Demography

Share to Odds Ratio

Share to Stents

Source

Open in PubMed Open full text

Identifiers

PMID: 28785581
DOI: 10.1155/2017/5783719
PMCID: PMC5530410

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP2C19⁎2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls.PMID 28785581Read ↗

CYP2C19*2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel: A matched case-control studySemantic proximity Read ↗

CYP2C19*2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel: a matched case-control study.Semantic proximity Read ↗

The association between CYP2C19 genotype and of in-stent restenosis among patients with vertebral artery stent treatment.Semantic proximity Read ↗

Clinical Outcomes after Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms: Evidence from a Chinese CohortSemantic proximity Read ↗

Association between CYP2C19 polymorphisms and clinical outcomes in patients undergoing stent procedure for cerebral artery stenosis.Semantic proximity Read ↗

Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects.Semantic proximity Read ↗

Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty.Semantic proximity Read ↗

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.Semantic proximity Read ↗

Association of CYP2C19*2 polymorphism with clopidogrel resistance among patients with high cardiovascular risk in Northeastern Mexico.Semantic proximity Read ↗

Clinical Outcomes After Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms.Semantic proximity Read ↗

Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?Semantic proximity Read ↗

[Influence of CYP2C19 gene polymorphisms on the efficacy of clopidogrel treatment for the prevention of ischemic stroke following coronary stent implantation].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.